France recalls 260,000 defective condoms over bursting and perforation risks

On Friday, French health and anti-fraud authorities announced the recall of roughly 260,000 condoms distributed through major online marketplaces, warning that the products posed genuine risks to users' sexual health and reproductive safety. The agencies—the DGCCRF anti-fraud office and the DGS health authority—had identified two non-compliant batches through laboratory testing, discovering that some condoms were prone to bursting while others contained actual perforations in the material itself.

The scale of the problem became clear when authorities disclosed that approximately 40,000 individual condoms from the affected batches had already reached consumers before the recall was issued. Most of the defective stock had been sold online by Asian vendors operating through major e-commerce platforms, making them easy to purchase but difficult to track. The condoms in question—including products under the Okamoto Industries brand and the MyLubie and Friday Bae labels from Passage du Desir—lacked the CE marking required to certify compliance with European Economic Area standards. Beyond the missing certification, the agencies noted that most of the packaging was not in French, and the products had not undergone third-party conformity assessment, all red flags that should have prevented their sale in the first place.

What made this recall particularly urgent was not merely the mechanical failure of the products themselves, but the cascade of health consequences that could follow. A condom that bursts or perforates during use offers no protection against sexually transmitted infections or pregnancy. The government agencies were direct about this: they advised anyone who had used the recalled condoms to seek STI screening and, if there was any possibility of conception—a missed or late period, for instance—to take a pregnancy test. The statement framed these tests not as optional precautions but as necessary steps for people who had unknowingly relied on defective protection.

The vendors involved had agreed to cooperate with the recall, removing the affected product listings from their platforms and committing to return the stock to authorities. Yet the fact that 40,000 condoms had already circulated before the intervention raised uncomfortable questions about how such products had entered the market in the first place and how long they might have been available for purchase before anyone noticed the defects.

France has invested in sexual health infrastructure in recent years, offering free condoms to people up to age 25 through pharmacies without requiring a prescription—a public health measure designed to reduce both STI transmission and unintended pregnancies. The discovery of defective condoms being sold online, often cheaper than regulated alternatives, underscored a persistent tension in consumer protection: the ease with which substandard products can slip through digital marketplaces, especially when sold by vendors operating across borders. The recall served as a reminder that even basic protective devices require vigilance, and that the infrastructure supporting sexual health is only as strong as the products flowing through it.